-
1 Comment
Zhejiang Zhenyuan Share Co., Ltd is currently in a long term downtrend where the price is trading 3.0% below its 200 day moving average.
From a valuation standpoint, the stock is 92.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Zhejiang Zhenyuan Share Co., Ltd's total revenue rose by 11.6% to $965M since the same quarter in the previous year.
Its net income has dropped by 86.5% to $20M since the same quarter in the previous year.
Finally, its free cash flow fell by 41.6% to $80M since the same quarter in the previous year.
Based on the above factors, Zhejiang Zhenyuan Share Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE0000007L4 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Market Cap | 3B |
|---|---|
| PE Ratio | 48.56 |
| Target Price | 16 |
| Dividend Yield | 0.8% |
| Beta | 0.47 |
Zhejiang Zhenyuan Share Co.,Ltd. manufactures and wholesales pharmaceuticals in China and internationally. It offers Chinese herbal medicines, herbal medicine slices, and patent medicine; and pharmaceutical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provides pharmaceutical logistics, health services, etc.; produces, wholesales, and retails medicines, pre-packaged food, and dairy products, such as infant formula milk powder. The company was incorporated in 1993 and is based in Shaoxing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000705.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
